Modulation of parvalbumin interneuron number by developmentally transient neocortical vasopressin receptor 1a (V1aR)

Neuroscience

Volumn 222, Issue , 2012, Pages 20-28

  Hammock, E A D ^a   Levitt, P ^b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

C57BL 6J; Calbindin; Parvalbumin; Post natal development; Sex difference; Vasopressin 1a receptor

Indexed keywords

CALBINDIN; PARVALBUMIN; VASOPRESSIN V1A RECEPTOR;

AGE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN MAPPING; CELL COUNT; FEMALE; HIPPOCAMPAL CA1 REGION; INTERNEURON; INTRACELLULAR SIGNALING; LIGAND BINDING; MALE; MOUSE; NEOCORTEX; NERVE CELL DIFFERENTIATION; NERVE CELL INHIBITION; NERVE CELL STIMULATION; NEUROMODULATION; NEWBORN; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; SEX DIFFERENCE;

ANIMALS; ARGININE VASOPRESSIN; AUTORADIOGRAPHY; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; FEMALE; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; INTERNEURONS; MALE; MICE; MICE, INBRED C57BL; NEOCORTEX; PARVALBUMINS; RECEPTORS, VASOPRESSIN; SEX CHARACTERISTICS;

EID: 84864940549     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.07.025     Document Type: Article

References (61)

1. Abercrombie M. Estimation of nuclear population from microtome sections. Anat Rec 1946, 94:239-247.
2. Albizu L., Balestre M.N., Breton C., Pin J.P., Manning M., Mouillac B., Barberis C., Durroux T. Probing the existence of G protein-coupled receptor dimers by positive and negative ligand-dependent cooperative binding. Mol Pharmacol 2006, 70:1783-1791.
3. Allen Brain Atlas Resources [Internet]. Seattle (WA): Allen Institute for Brain Science. ©2009. Available from: http://www.brain-map.org.
4. Beery A.K., Lacey E.A., Francis D.D. Oxytocin and vasopressin receptor distributions in a solitary and a social species of tuco-tuco (Ctenomys haigi and Ctenomys sociabilis). J Comp Neurol 2008, 507:1847-1859.
5. Belmonte M.K., Cook E.H., Anderson G.M., Rubenstein J.L., Greenough W.T., Beckel-Mitchener A., Courchesne E., Boulanger L.M., Powell S.B., Levitt P.R., Perry E.K., Jiang Y.H., DeLorey T.M., Tierney E. Autism as a disorder of neural information processing: directions for research and targets for therapy. Mol Psychiatry 2004, 9:646-663.
6. Boer G.J., Uylings H.B., Patel A.J., Boer K., Kragten R. The regional impairment of brain development in the Brattleboro diabetes insipidus rat; some vasopressin supplementation studies. Ann N Y Acad Sci 1982, 394:703-717.
7. Boer G.J., Van Rheenen-Verberg C.M., Uylings H.B. Impaired brain development of the diabetes insipidus Brattleboro rat. Brain Res 1982, 255:557-575.
8. Campbell P., Ophir A.G., Phelps S.M. Central vasopressin and oxytocin receptor distributions in two species of singing mice. J Comp Neurol 2009, 516:321-333.
9. Chao H.T., Chen H., Samaco R.C., Xue M., Chahrour M., Yoo J., Neul J.L., Gong S., Lu H.C., Heintz N., Ekker M., Rubenstein J.L., Noebels J.L., Rosenmund C., Zoghbi H.Y. Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes. Nature 2010, 468:263-269.
10. Clancy B., Kersh B., Hyde J., Darlington R.B., Anand K.J., Finlay B.L. Web-based method for translating neurodevelopment from laboratory species to humans. Neuroinformatics 2007, 5:79-94.
11. de Leon J., Verghese C., Tracy J.I., Josiassen R.C., Simpson G.M. Polydipsia and water intoxication in psychiatric patients: a review of the epidemiological literature. Biol Psychiatry 1994, 35:408-419.
12. Delva N.J., Crammer J.L., Lawson J.S., Lightman S.L., Sribney M., Weier B.J. Vasopressin in chronic psychiatric patients with primary polydipsia. Br J Psychiatry 1990, 157:703-712.
13. Delville Y., Mansour K.M., Quan E.W., Yules B.M., Ferris C.F. Postnatal development of the vasopressinergic system in golden hamsters. Brain Res Dev Brain Res 1994, 81:230-239.
14. Donaldson Z.R., Young L.J. Oxytocin, vasopressin, and the neurogenetics of sociality. Science 2008, 322:900-904.
15. Dubois-Dauphin M., Barberis C., De Bilbao F. Vasopressin receptors in the mouse (Mus musculus) brain: sex-related expression in the medial preoptic area and hypothalamus. Brain Res 1996, 743:32-39.
16. Eagleson K.L., Bonnin A., Levitt P. Region- and age-specific deficits in gamma-aminobutyric acidergic neuron development in the telencephalon of the uPAR(-/-) mouse. J Comp Neurol 2005, 489:449-466.
17. Eagleson K., Hammock E.A.D., Levitt P. Interneuron pathophysiologies: paths to neurodevelopmental disorders. Developmental plasticity of inhibitory circuitry 2010, Springer, New York. S.L. Pallas (Ed.).
18. Frank E., Landgraf R. The vasopressin system-from antidiuresis to psychopathology. Eur J Pharmacol 2008, 583:226-242.
19. Gogolla N., Leblanc J.J., Quast K.B., Sudhof T.C., Fagiolini M., Hensch T.K. Common circuit defect of excitatory-inhibitory balance in mouse models of autism. J Neurodev Disord 2009, 1:172-181.
20. Goldman M.B., Robertson G.L., Luchins D.J., Hedeker D., Pandey G.N. Psychotic exacerbations and enhanced vasopressin secretion in schizophrenic patients with hyponatremia and polydipsia. Arch Gen Psychiatry 1997, 54:443-449.
21. Hammock E.A., Young L.J. Microsatellite instability generates diversity in brain and sociobehavioral traits. Science 2005, 308:1630-1634.
22. Hammock E.A., Young L,J. Oxytocin, vasopressin and pair bonding: implications for autism. Philos Trans R Soc Lond B Biol Sci 2006, 361:2187-2198.
23. Hashimoto T., Volk D.W., Eggan S.M., Mirnics K., Pierri J.N., Sun Z., Sampson A.R., Lewis D.A. Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J Neurosci 2003, 23:6315-6326.
24. Hensch T.K. Critical period plasticity in local cortical circuits. Nat Rev Neurosci 2005, 6:877-888.
25. Hu S.B., Zhao Z.S., Yhap C., Grinberg A., Huang S.P., Westphal H., Gold P. Vasopressin receptor 1a-mediated negative regulation of B cell receptor signaling. J Neuroimmunol 2003, 135:72-81.
26. Johnson A.E., Audigier S., Rossi F., Jard S., Tribollet E., Barberis C. Localization and characterization of vasopressin binding sites in the rat brain using an iodinated linear AVP antagonist. Brain Res 1993, 622:9-16.
27. Kim S.J., Young L.J., Gonen D., Veenstra-VanderWeele J., Courchesne R., Courchesne E., Lord C., Leventhal B.L., Cook E.H., Insel T.R. Transmission disequilibrium testing of arginine vasopressin receptor 1A (AVPR1A) polymorphisms in autism. Mol Psychiatry 2002, 7:503-507.
28. Kishimoto T., Hirai M., Ohsawa H., Terada M., Matsuoka I., Ikawa G. Manners of arginine vasopressin secretion in schizophrenic patients-with reference to the mechanism of water intoxication. Jpn J Psychiatry Neurol 1989, 43:161-169.
29. Knafo A., Israel S., Darvasi A., Bachner-Melman R., Uzefovsky F., Cohen L., Feldman E., Lerer E., Laiba E., Raz Y., Nemanov L., Gritsenko I., Dina C., Agam G., Dean B., Bornstein G., Ebstein R.P. Individual differences in allocation of funds in the dictator game associated with length of the arginine vasopressin 1a receptor RS3 promoter region and correlation between RS3 length and hippocampal mRNA. Genes Brain Behav 2008, 7:266-275.
30. Kuehl-Kovarik M.C., Iqbal J., Jacobson C.D. Autoradiographic localization of arginine vasopressin binding sites in the brain of adult and developing Brazilian opossums. Brain Behav Evol 1997, 49:261-275.
31. Kuhlman S.J., Lu J., Lazarus M.S., Huang Z.J. Maturation of GABAergic inhibition promotes strengthening of temporally coherent inputs among convergent pathways. PLoS Comput Biol 2010, 6:e1000797.
32. Levitt P., Eagleson K.L., Powell E.M. Regulation of neocortical interneuron development and the implications for neurodevelopmental disorders. Trends Neurosci 2004, 27:400-406.
33. Lewis D.A., Hashimoto T., Volk D.W. Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci 2005, 6:312-324.
34. Lim M., Hammock E., Young L. A method for acetylcholinesterase staining of brain sections previously processed for receptor autoradiography. Biotech Histochem 2004, 79:11-16.
35. Manning M., Klis W.A., Kruszynski M., Przybylski J.P., Olma A., Wo N.C., Pelton G.H., Sawyer W.H. Novel linear antagonists of the antidiuretic (V2) and vasopressor (V1) responses to vasopressin. Int J Pept Protein Res 1988, 32:455-467.
36. Ohsawa H., Kishimoto T., Shimayoshi N., Matsumura K., Tahara K., Kitera K., Higashiura N., Noriyama Y., Matsumoto H., Hirai M., et al. Atrial natriuretic peptide and arginine vasopressin secretion in schizophrenic patients. Acta Psychiatr Scand 1993, 88:130-134.
37. Ostrowski N.L., Lolait S.J., Young W.S. 3rd Cellular localization of vasopressin V1a receptor messenger ribonucleic acid in adult male rat brain, pineal, and brain vasculature. Endocrinology 1994, 135:1511-1528.
38. Packer A.M., Yuste R. Dense, unspecific connectivity of neocortical parvalbumin-positive interneurons: a canonical microcircuit for inhibition?. J Neurosci 2011, 31:13260-13271.
39. Paxinos G., Franklin K.B.J. The mouse brain in stereotaxic coordinates 2001, Academic Press, San Diego.
40. Petracca F.M., Baskin D.G., Diaz J., Dorsa D.M. Ontogenetic changes in vasopressin binding site distribution in rat brain: an autoradiographic study. Brain Res 1986, 393:63-68.
41. Powell E.M., Campbell D.B., Stanwood G.D., Davis C., Noebels J.L., Levitt P. Genetic disruption of cortical interneuron development causes region- and GABA cell type-specific deficits, epilepsy, and behavioral dysfunction. J Neurosci 2003, 23:622-631.
42. Rabhi M., Stoeckel M.E., Calas A., Freund-Mercier M.J. Historadioautographic localisation of oxytocin and vasopressin binding sites in the central nervous system of the merione (Meriones shawi). Brain Res Bull 1999, 48:147-163.
43. Rubenstein J.L., Merzenich M.M. Model of autism: increased ratio of excitation/inhibition in key neural systems. Genes Brain Behav 2003, 2:255-267.
44. Ryan M.C., Sharifi N., Condren R., Thakore J.H. Evidence of basal pituitary-adrenal overactivity in first episode, drug naive patients with schizophrenia. Psychoneuroendocrinology 2004, 29:1065-1070.
45. Schmidt A., Audigier S., Barberis C., Jard S., Manning M., Kolodziejczyk A.S., Sawyer W.H. A radioiodinated linear vasopressin antagonist: a ligand with high affinity and specificity for V1a receptors. FEBS Lett 1991, 282:77-81.
46. Snijdewint F.G., Van Leeuwen F.W., Boer G.J. Ontogeny of vasopressin and oxytocin binding sites in the brain of Wistar and Brattleboro rats as demonstrated by lightmicroscopical autoradiography. J Chem Neuroanat 1989, 2:3-17.
47. Szot P., Myers K.M., Swank M., Dorsa D.M. Characterization of a 3H-arginine8-vasopressin binding site in the cingulate gyrus of the rat pup. Peptides 1989, 10:1231-1237.
48. Szot P., Myers K.M., Dorsa D.M. Effect of vasopressin administration and deficiency upon 3H-AVP binding sites in the CNS and periphery during development. Peptides 1992, 13:389-394.
49. Tanoue A., Ito S., Honda K., Oshikawa S., Kitagawa Y., Koshimizu T.A., Mori T., Tsujimoto G. The vasopressin V1b receptor critically regulates hypothalamic-pituitary-adrenal axis activity under both stress and resting conditions. J Clin Invest 2004, 113:302-309.
50. Tribollet E., Goumaz M., Raggenbass M., Dreifuss J.J. Appearance and transient expression of vasopressin and oxytocin receptors in the rat brain. J Recept Res 1991, 11:333-346.
51. Tribollet E., Goumaz M., Raggenbass M., Dubois-Dauphin M. Early appearance and transient expression of vasopressin receptors in the brain of rat fetus and infant. An autoradiographical and electrophysiological study. Brain Res Dev Brain Res 1991, 58:13-24.
52. Wang Z., Young L.J. Ontogeny of oxytocin and vasopressin receptor binding in the lateral septum in prairie and montane voles. Brain Res Dev Brain Res 1997, 104:191-195.
53. Wang Z., Liu Y., Young L.J., Insel T.R. Developmental changes in forebrain vasopressin receptor binding in prairie voles (Microtus ochrogaster) and montane voles (Microtus montanus). Ann N Y Acad Sci 1997, 807:510-513.
54. Wang Z., Young L.J., Liu Y., Insel T.R. Species differences in vasopressin receptor binding are evident early in development: comparative anatomic studies in prairie and montane voles. J Comp Neurol 1997, 378:535-546.
55. Wassink T.H., Piven J., Vieland V.J., Pietila J., Goedken R.J., Folstein S.E., Sheffield V.C. Examination of AVPR1a as an autism susceptibility gene. Mol Psychiatry 2004, 9:968-972.
56. Wonders C.P., Anderson S.A. The origin and specification of cortical interneurons. Nat Rev Neurosci 2006, 7:687-696.
57. Yang S.Y., Cho S.C., Yoo H.J., Cho I.H., Park M., Kim B.N., Kim J.W., Shin M.S., Park T.W., Son J.W., Chung U.S., Kim H.W., Yang Y.H., Kang J.O., Kim S.A. Association study between single nucleotide polymorphisms in promoter region of AVPR1A and Korean autism spectrum disorders. Neurosci Lett 2010, 479:197-200.
58. Yang S.Y., Cho S.C., Yoo H.J., Cho I.H., Park M., Yoe J., Kim S.A. Family-based association study of microsatellites in the 5' flanking region of AVPR1A with autism spectrum disorder in the Korean population. Psychiatry Res 2010, 178:199-201.
59. Yirmiya N., Rosenberg C., Levi S., Salomon S., Shulman C., Nemanov L., Dina C., Ebstein R.P. Association between the arginine vasopressin 1a receptor (AVPR1a) gene and autism in a family-based study: mediation by socialization skills. Mol Psychiatry 2006, 11:488-494.
60. Yizhar O., Fenno L.E., Prigge M., Schneider F., Davidson T.J., O'Shea D.J., Sohal V.S., Goshen I., Finkelstein J., Paz J.T., Stehfest K., Fudim R., Ramakrishnan C., Huguenard J.R., Hegemann P., Deisseroth K. Neocortical excitation/inhibition balance in information processing and social dysfunction. Nature 2011, 477:171-178.
61. Young L.J. Frank A. Beach Award. Oxytocin and vasopressin receptors and species-typical social behaviors. Horm Behav 1999, 36:212-221.